BCR::ABL1 breakpoint and mutation profiling for hemato-oncology research workflows. Offered by Genient Technologies as part of its expanded Oncology NGS portfolio.
A targeted NGS kit for laboratories evaluating BCR::ABL1 in hemato-oncology samples, with a workflow built around fastGEN library preparation and GENOVESA analysis support.
A quick view of the product fit, marker scope, and workflow notes for laboratory planning.
RUO. Availability and intended use can vary by market; contact Genient for current guidance.
BCR::ABL1
Isolated DNA sequencing workflow support.
GENOVESA cloud workflow support for FASTQ analysis and reporting discussions.
Our team can help with assay selection, availability, implementation planning, and sequencing workflow fit.
